Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

BUTRANS 5 MCG/HR PATCH

buprenorphine
$48.9026per EA
DEA Schedule CIII

Strength

5 ug/h

Manufacturer

Purdue Pharma LP

NDC

59011075004

Classification

Brand

Dosage Form

PATCH, EXTENDED RELEASE

Route

TRANSDERMAL

Last Updated

4/22/2026

Active Ingredients

BUPRENORPHINE

Approval Type

New Drug (NDA)

FDA Application

NDA021306

On Market Since

2/14/2011

Pharmacological Classes

Partial Opioid Agonist
Partial Opioid Agonists

Price History

1W

0.0%

1M

+0.0%

3M

-0.0%

6M

-0.1%

1Y

-0.2%

3Y

-42.9%

5Y

-37.0%

All

+35.2%

Generic Alternatives

Save up to 57%

1 alternative • Same active ingredient

BUPRENORPHINE 5 MCG/HR PATCH
Generic
47781040604•Alvogen Inc.
$20.9308
Save 57%

Related Drugs

Same classification

SUBOXONE 2 MG-0.5 MG SL FILM
Brand
12496120203•Indivior Inc.
$4.7853
per EA
ZUBSOLV 0.7-0.18 MG TABLET SL
Brand
54123090730•Orexo US, Inc.
$5.2599
per EA
ZUBSOLV 1.4-0.36 MG TABLET SL
Brand
54123091430•Orexo US, Inc.
$5.2767
per EA
BELBUCA 150 MCG FILM
Brand
59385002260•BioDelivery Sciences International Inc
$7.5560
per EA
BELBUCA 75 MCG FILM
Brand
59385002160•BioDelivery Sciences International Inc
$7.5635
per EA
SUBOXONE 4 MG-1 MG SL FILM
Brand
12496120403•Indivior Inc.
$8.5848
per EA
SUBOXONE 8 MG-2 MG SL FILM
Brand
12496120803•Indivior Inc.
$8.5983
per EA
ZUBSOLV 2.9-0.71 MG TABLET SL
Brand
54123092930•Orexo US, Inc.
$10.5396
per EA
ZUBSOLV 5.7-1.4 MG TABLET SL
Brand
54123095730•Orexo US, Inc.
$10.5559
per EA
BELBUCA 300 MCG FILM
Brand
59385002360•BioDelivery Sciences International Inc
$11.8705
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy